Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EXAGEN INC. | 839,834 | reported | 12 Mar 2026 | tx 17+1,147,969−92,734 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2026 | GRANT_AWARD | EXAGEN INC. | 150,000 | 0.00 USD | |
| 12 Mar 2026 | GRANT_AWARD | EXAGEN INC. | 100,000 | 3.16 USD | deriv |
| 03 Mar 2026 | GRANT_AWARD | EXAGEN INC. | 2,535 | 3.08 USD | |
| 03 Mar 2026 | SALE | EXAGEN INC. | 15,698 | 3.62 USD | |
| 24 Feb 2026 | SALE | EXAGEN INC. | 11,430 | 3.61 USD | |
| 16 Oct 2025 | SALE | EXAGEN INC. | 31,787 | 11.82 USD | |
| 28 Feb 2025 | GRANT_AWARD | EXAGEN INC. | 8,621 | 2.47 USD | |
| 21 Feb 2025 | GRANT_AWARD | EXAGEN INC. | 112,500 | 0.00 USD | |
| 21 Feb 2025 | GRANT_AWARD | EXAGEN INC. | 75,000 | 3.58 USD | deriv |
| 14 Nov 2024 | PURCHASE | EXAGEN INC. | 24,305 | 2.81 USD | |
| 16 May 2024 | PURCHASE | EXAGEN INC. | 40,401 | 1.92 USD | first after silence |
| 29 Feb 2024 | GRANT_AWARD | EXAGEN INC. | 9,804 | 1.91 USD | |
| 20 Feb 2024 | GRANT_AWARD | EXAGEN INC. | 175,000 | 0.00 USD | |
| 17 Oct 2023 | SALE | EXAGEN INC. | 33,819 | 1.75 USD | |
| 31 Aug 2023 | GRANT_AWARD | EXAGEN INC. | 9,803 | 2.14 USD | |
| 08 Dec 2022 | PURCHASE | EXAGEN INC. | 90,000 | 2.68 USD | |
| 16 Oct 2022 | GRANT_AWARD | EXAGEN INC. | 350,000 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 16 May 2024.